NPL-2003

N/A

Report date: 2022/11/25 17:01:28
NME

Base Information

Drug NameNPL-2003
Drug Alias NameNPL 2003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamates modulators
TargetsGlutamates
Therapy Area/IndicationsObsessive-Compulsive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeuropharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York State Psychiatric InstituteNeuropharm Inc
Active IndicationsN/A
Inactive IndicationsObsessive-Compulsive Disorder

Other Information

ATC CodeN/A
Related LinksN/A